Nasal Valve Dysfunction after Mohs Surgery for Skin Cancer of the Nose

1998 ◽  
Vol 24 (9) ◽  
pp. 1011-1017 ◽  
Author(s):  
MICHAEL B. REYNOLDS ◽  
FREDERICK W. GOURDIN
Keyword(s):  
Skin Cancer ◽  
Nasal Valve ◽  
Mohs Surgery ◽  
Valve Dysfunction

scholarly journals Costal Cartilage Lateral Crural Strut Graft for Correction of External Nasal Valve Dysfunction in Primary and Revision Rhinoplasty

2021 ◽  
pp. 014556132098394
Author(s):  
Mohamed A. Taha ◽  
Christian A. Hall ◽  
Harry E. Zylicz ◽  
William T. Barham ◽  
Margaret B. Westbrook ◽  
...  
Keyword(s):  
Costal Cartilage ◽  
Primary Group ◽  
Nasal Valve ◽  
Lateral Crus ◽  
Valve Dysfunction ◽  
Score Improvement ◽  
Revision Rhinoplasty ◽  
Final Score ◽  
Sinonasal Outcome Test ◽  
External Nasal Valve

Objective: To evaluate and compare the costal cartilage lateral crural strut graft’s (LCSG) ability to support a weak lateral crus in patients with external nasal valve dysfunction (EVD) undergoing primary versus revision functional rhinoplasty. Methods: This is a prospective cohort study of 26 patients (mean [SD]: 40.23 [6.75] years of age; 10 [38%] females) with clinically diagnosed EVD, who underwent primary versus revision functional rhinoplasty with the use of a costal cartilage LCSG (10 [38%] primary functional rhinoplasty patients and the 16 [62%] revision patients). Preoperative and 12-month postoperative subjective and objective functional measurements along with statistical analysis were performed. Results: While all baseline demographic and preoperative functional measurement scores were similar between the 2 groups, the primary cohort’s preoperative scores were higher overall. Follow-up was a mean of 14.58 months. The primary group demonstrated a greater difference in score improvement postoperatively in all categories. All patients had significantly improved visual analog scale (VAS), Nasal Obstruction Symptom Evaluation Scale, 22-Item Sinonasal Outcome Test, and nasal peak inspiratory flow (NPIF) scores. When comparing the overall score outcome and surgical efficacy of the LCSG, both groups had near equal final score outcomes with the exception of VASL and NPIF. Conclusion: The LCSG is a viable and versatile option in the management of EVD for both primary and revision rhinoplasty patients.

Modified alar batten grafts for treatment in nasal valve dysfunction: Our experience.

2021 ◽  
Author(s):  
Alberto Raposo ◽  
Jerónimo Lajara ◽  
Alberto Guillén ◽  
Francisco García-Purriños
Keyword(s):  
Nasal Valve ◽  
Valve Dysfunction

An Adjustable Implant for the Nasal Valve: 3-Year Experience

2008 ◽  
Vol 139 (2_suppl) ◽  
pp. P72-P72
Author(s):  
Charles G Hurbis
Keyword(s):  
Nasal Valve ◽  
Valve Dysfunction ◽  
Nasal Airways ◽  
Quality Of Life Scale ◽  
Life Scale ◽  
Nasal Implant ◽  
Scale Data ◽  
Implantation Success

Objective 1) Measure the effectiveness of the Monarch implant in correcting nasal valve dysfunction. 2) Determine the longevity of effectiveness. Methods This study consists of a prospective, cumulative, three-year experience with the Monarch adjustable nasal implant for correcting nasal valve dysfunction in a total of 46 patients. Implantation success was determined by the use of acoustic rhinomanometry and a subjective NOSE-type quality of life scale. Data was subjected to the student-t test. Results In the series of 46 patients spanning 36 months there is a mean 150% improvement in the internal nasal valve areas at 3 years as measured by acoustic rhinomanometry (p<.0001). Using a NOSE-type questionnaire, patients also noted significant improvements in daytime (p<.0004) and nighttime (p<.0002) nasal airways, a decrease in apnea (p<.01) and snoring (p<.05), and a decrease in the propensity for daytime oral breathing (p<.0002). Conclusions The Monarch Implant provides a simple, consistent, adjustable and apparently long-term correction of the nasal airway in patients suffering from nasal valvular dysfunction.

Second-intention healing of exposed facial-scalp bone after Mohs surgery for skin cancer: Review of ninety-one cases

1994 ◽  
Vol 31 (3) ◽  
pp. 450-454 ◽  
Author(s):  
Stephen N. Snow ◽  
Mark A. Stiff ◽  
Ricardo Bullen ◽  
Frederic E. Mohs ◽  
Wei-Hsiung Chao
Keyword(s):  
Skin Cancer ◽  
Mohs Surgery ◽  
Cancer Review

How Mohs Surgery Transformed Into a First-Line Treatment of Skin Cancer

2016 ◽  
Vol 21 (1) ◽  
pp. 40-41 ◽  
Author(s):  
Rob Bobotsis ◽  
Lyn Guenther
Keyword(s):  
Skin Cancer ◽  
Cancer Cells ◽  
Surgical Margins ◽  
Line Treatment ◽  
First Line ◽  
Mohs Surgery ◽  
The Real ◽  
Skin Cancers ◽  
Widespread Acceptance ◽  
First Line Treatment

Mohs surgery is considered ideal treatment for many types of skin cancers. Developed by Dr Frederic Edward Mohs (1910-2002), Mohs surgery allows all surgical margins to be viewed microscopically, ensuring no cancer cells go unremoved, yet it failed to achieve immediate acceptance when first introduced in the 1940s. A catalyst to the widespread acceptance of Mohs surgery occurred with the work of dermatologic colleagues who reported excellent results without using the paste. It suggested the real innovation of Mohs surgery lay in its microscopic control and not the paste, the discontinuation of which removed all the problems associated with its use.

A Novel Nonparametric Technique for Segmenting Multimode Hyperspectral Images Obtained From Non-Melanoma Skin Cancer Lesions

2020 ◽  
Author(s):  
Gamal G. N. Geweid ◽  
Fartash Vasefi ◽  
Kouhyar Tavakolian
Keyword(s):  
Skin Cancer ◽  
Cell Carcinoma ◽  
Imaging System ◽  
Public Awareness ◽  
Hyperspectral Images ◽  
Mohs Surgery ◽  
Non Melanoma Skin Cancer ◽  
Potential Applications ◽  
Experimental Findings ◽  
Melanoma Skin

Abstract Keratinocyte Carcinoma, more traditionally known as Non-melanoma skin cancer (NMSC), is the most common cancer in humans. Incidence continues to increase despite increased public awareness of the harmful effects of solar radiation. In this paper, a non-parametric technique based on image registration will be applied to the multimode hyperspectral imaging system to segment Basal Cell Carcinoma (BCC) and Squamous cell carcinoma lesions (SCC). The aim is to enhance Mohs surgery by determining the actual borderlines of the desired area in the patient’s images, leading to increased efficiency and efficacy of the Mohs surgery. The proposed algorithm was applied to four sets of different Multimode hyperspectral Images with Non-Melanoma Skin. The experimental findings showed that the proposed algorithm is effective in Non-Melanoma skin detection. This could lead to improved image-guided excision of cancerous lesions with potential applications in robotic interventions.

Sign in / Sign up

Export Citation Format

Share Document